State-level oversight of M&A and other strategic transactions involving healthcare is continuing to expand into new markets and impact growth strategies. The interest and need for healthcare services transactions in the United States continues, as providers, payors, investors, and others develop and adapt to new delivery models aimed at addressing systemic problems related to access, quality, outcomes, competition, and cost. New collaborations between providers, payors, and strategic partners, along with access to private capital, have, in significant part, driven the reconfiguration.
Read the full article: US State Regulatory Spotlight on Healthcare Transactions: Reflections from 2024 //
Source: https://www.jdsupra.com/legalnews/us-state-regulatory-spotlight-on-5441863/